We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Functional and medicinal mushrooms ranked by clinical evidence — cognition, immunity, energy, and more.
Top picks: Turkey Tail, Cordyceps, and Lion's Mane.
Immune-supporting mushroom with the strongest evidence among medicinal mushrooms, used as cancer therapy adjunct in Asia.
A traditional fungus marketed for energy and endurance. The honest verdict: those claims rest on small, often-mixed trials — several found no benefit — while the stronger evidence covers adjuvant kidney and COPD use instead.
Stimulates nerve growth factor (NGF) through hericenones and erinacines — supports cognition, nerve repair, and brain health.
A culinary mushroom containing lentinan and eritadenine. Human evidence is limited to small RCTs — preliminary immune signals and a modest triglyceride effect, with no large trials or meta-analyses.
A traditional calming mushroom rich in beta-glucans and triterpenes. The honest verdict: most evidence is preclinical or review-level; human RCTs are few, small, and mixed, and Cochrane found insufficient evidence for cancer or cardiovascular use.
A culinary mushroom whose polysaccharides hold a lot of water in the lab. The honest verdict: the popular skin-hydration claims rest on mechanism, not human trials — there are no skin-outcome RCTs, only a couple of small cognition studies.
Rare old-growth mushroom with antiviral compounds studied for immune defense — one of the oldest medicinal fungi known to science.
A birch fungus rich in antioxidant compounds in the lab. The honest verdict: the human evidence is essentially absent — no clinical trials, only cell, animal, and review data.
A beta-glucan-rich mushroom (D-fraction). The honest verdict: human evidence is limited to a few small trials in niche patient groups (cancer, MDS, PCOS) — there's little direct support for the general immune or blood-sugar claims it's marketed for.